BridgeBio Pharma, Inc. (BBIO)
72.38
-0.06
(-0.08%)
USD |
NASDAQ |
Sep 14, 16:00
72.12
-0.26
(-0.36%)
After-Hours: 07:53
BridgeBio Pharma Price : 72.38 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 72.55 | 73.67 | 72.16 | 72.38 | 1.851M |
| Sep 11, 2026 | 73.22 | 74.10 | 71.98 | 72.44 | 1.767M |
| Sep 10, 2026 | 75.27 | 75.50 | 72.12 | 72.50 | 3.065M |
| Sep 09, 2026 | 73.63 | 76.81 | 73.46 | 76.08 | 2.307M |
| Sep 08, 2026 | 73.60 | 76.34 | 73.26 | 74.76 | 2.095M |
| Sep 04, 2026 | 74.98 | 75.36 | 74.11 | 74.84 | 1.539M |
| Sep 03, 2026 | 76.43 | 76.64 | 75.20 | 75.41 | 1.098M |
| Sep 02, 2026 | 76.60 | 78.25 | 75.96 | 76.50 | 1.621M |
| Sep 01, 2026 | 76.61 | 77.45 | 76.22 | 76.57 | 1.448M |
| Aug 31, 2026 | 76.20 | 77.24 | 75.02 | 76.59 | 2.064M |
| Aug 28, 2026 | 79.99 | 80.55 | 76.34 | 76.60 | 1.922M |
| Aug 27, 2026 | 79.25 | 79.72 | 78.34 | 78.68 | 1.034M |
| Aug 26, 2026 | 79.75 | 80.76 | 79.33 | 79.37 | 1.705M |
| Aug 25, 2026 | 81.89 | 82.50 | 80.20 | 80.40 | 1.469M |
| Aug 24, 2026 | 80.98 | 81.68 | 80.16 | 81.07 | 1.113M |
| Aug 21, 2026 | 82.89 | 83.37 | 81.36 | 81.50 | 1.744M |
| Aug 20, 2026 | 83.51 | 84.36 | 82.63 | 82.94 | 2.031M |
| Aug 19, 2026 | 84.22 | 85.65 | 83.25 | 83.95 | 3.285M |
| Aug 18, 2026 | 80.54 | 83.95 | 80.10 | 82.98 | 2.718M |
| Aug 17, 2026 | 79.15 | 80.42 | 78.12 | 79.89 | 2.796M |
| Aug 14, 2026 | 80.14 | 80.56 | 78.60 | 79.86 | 3.094M |
| Aug 13, 2026 | 84.77 | 84.77 | 80.78 | 81.21 | 1.280M |
| Aug 12, 2026 | 83.47 | 84.99 | 82.82 | 83.84 | 2.794M |
| Aug 11, 2026 | 87.02 | 89.49 | 83.35 | 83.70 | 3.082M |
| Aug 10, 2026 | 83.45 | 86.00 | 83.45 | 84.67 | 2.943M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 249.99 |
| Ionis Pharmaceuticals, Inc. | 51.44 |
| Pfizer Inc. | 27.72 |
| Vertex Pharmaceuticals, Inc. | 519.51 |
| BioMarin Pharmaceutical, Inc. | 66.41 |
Price Related Metrics
| PS Ratio | 19.69 |
| Earnings Yield | -4.93% |
| Market Cap | 14.13B |